Name: Azelnidipine
Text:
Azelnidipine is an isopropyl ester.
Azelnidipine is a dihydropyridine calcium channel blocker. It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan.  It has a gradual onset of action and produces a long-lasting decrease in blood pressure, with only a small increase in heart rate, unlike some other calcium channel blockers. It is currently being studied for post-ischemic stroke management.
AZELNIDIPINE is a small molecule drug with a maximum clinical trial phase of III.
Properties:safety: Corrosive and Irritant
smiles: CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C
formula: C33H34N4O6
chem_properties: Molecular Weight: 582.6 g/mol
XLogP3: 6
Hydrogen Bond Donor Count: 2
Hydrogen Bond Acceptor Count: 9
Rotatable Bond Count: 10
Exact Mass: 582.24783482 Da
Monoisotopic Mass: 582.24783482 Da
Topological Polar Surface Area: 140
Heavy Atom Count: 43
Formal Charge: 0
Complexity: 1080
Isotope Atom Count: 0
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count: 1
Defined Bond Stereocenter Count: 0
Undefined Bond Stereocenter Count: 0
Covalently-Bonded Unit Count: 1
Compound Is Canonicalized: Yes 

